The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients with advanced urothelial cancer who develop infection while on treatment with pembrolizumab.
 
Ryan Blair Kieser
No Relationships to Disclose
 
Jiaqiong Xu
No Relationships to Disclose
 
Ethan Burns
No Relationships to Disclose
 
Ibrahim Muhsen
No Relationships to Disclose
 
Shivan M Shah
No Relationships to Disclose
 
Godsfavour Umoru
No Relationships to Disclose
 
Charisma Mylavarapu
No Relationships to Disclose
 
Kai Sun
No Relationships to Disclose
 
Yuqi Zhang
No Relationships to Disclose
 
Aubrey Crenshaw
No Relationships to Disclose
 
Abdullah Esmail
No Relationships to Disclose
 
Carlo Guerrero
No Relationships to Disclose
 
Zimu Gong
No Relationships to Disclose
 
Kelly Gee
No Relationships to Disclose
 
Kirk Heyne
No Relationships to Disclose
 
Monisha Singh
No Relationships to Disclose
 
Jun Zhang
No Relationships to Disclose
 
Eleni Efstathiou
Honoraria - Astellas Pharma; Janssen-Cilag; Merck; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bayer; Janssen Oncology; Myovant Sciences; Sanofi; Tokai Pharmaceuticals
Research Funding - Janssen-Cilag
 
Eric Bernicker
Consulting or Advisory Role - Blueprint Medicines
Speakers' Bureau - Blueprint Medicines
Research Funding - Genentech
 
Maen Abdelrahim
No Relationships to Disclose